Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

What you need to know about the coronavirus right now

Published 2021-05-06, 01:37 a/m
Updated 2021-05-06, 01:42 a/m

May 6 (Reuters) - Here's what you need to know about the coronavirus right now:

COVID-19 spreading in rural India

India reported a record 412,262 new COVID-19 cases on Thursday and a record 3,980 daily deaths, as a second wave of infections swamps the health system and spreads from cities into the vast countryside. Medical experts say India's actual figures could be five to 10 times the official tallies. India's healthcare system teeters on the verge of collapse, young doctors are having to make tough decisions during long workdays at hospitals across the country. curbs reinstated in Sydney

Australian officials reinstated social-distancing measures across greater Sydney on Thursday, as they scrambled to find missing transmission links in a COVID-19 case connected to an Indian variant of the virus.

With many people expected to gather over the weekend for annual Mother's Day celebrations, the New South Wales state government restricted household gatherings to 20 guests and limited aged-care facility visitors to two people per resident. Masks will be mandatory on public transport and at indoor venues. All the restrictions, which cover around 5.3 million people in the country's biggest metropolitan area, take effect at 5 p.m. local time and are scheduled to last until Monday morning. booster increases antibodies against COVID-19 variants

Moderna Inc said on Wednesday early human trial data shows that a third dose of either its current COVID-19 shot or an experimental new vaccine candidate increases immunity against variants of COVID-19 first found in Brazil and South Africa.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The early data comes from a 40-person trial testing both Moderna's existing shot and a version developed to protect against the South African variant of COVID-19 called mRNA-1273.351. Moderna is also studying a shot that combines both the new and existing vaccine. variants on the rise in Tokyo

Tokyo Governor Yuriko Koike said on Thursday that the number of new COVID-19 cases among younger people are on the rise and called on residents to further curtail their movements. Mutant variants of the virus are becoming dominant, and fears are growing that the surge could exceed the third wave that crested in January, Koike said at a meeting of health experts.

Tokyo plans to ask the central government on Thursday to extend the current state of emergency, local media reported, citing unnamed officials. tourism: Canadians fly south for shot

With COVID-19 vaccine demand declining in the United States, some Canadians facing third-wave lockdowns are flying south to get inoculated, perhaps months earlier than they would be able to at home.

While almost a third of Americans have been fully vaccinated, Canada has inoculated only 3% of its almost 38 million people, though more than 34% have received a first dose. Canada is allowing for a four-month gap between doses, while Americans are getting their second shots three or four weeks after the first to reach optimal protection much sooner.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.